BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8055472)

  • 1. Early blastic transformation of a myeloproliferative disorder with t(8;21) and progressive aberrations of chromosome 8.
    Fasanaro A; Paone G; Silvestri I; Marottoli V; Cimino R; Ferrara F
    Cancer Genet Cytogenet; 1994 Jul; 75(2):106-10. PubMed ID: 8055472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukaemia with t(8;21)(q22;q22.3) and loss of the X chromosome.
    Mohamed M; Dun K
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26250367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia (AML-M1) with multiple trisomies and t(8;21)(q22;q22).
    Köhler M; Johansson B; Ludvigsson J; Aman P; Heim S; Mitelman F
    Cancer Genet Cytogenet; 1994 Mar; 73(1):79-81. PubMed ID: 8174079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
    Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
    Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelomonocytic leukemia with trisomy 8 and a related clone with trisomy 8 and t(15;17).
    Dalton WT; Cork A; Stass SA; Trujillo JM
    Cancer Genet Cytogenet; 1988 Jun; 32(2):287-92. PubMed ID: 3163267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Karyotype in chronic myeloid leukemia in a blastic crisis. I. Monosomy 16].
    Palka G; Geraci L; Caramelli E; Marino M; Felaco M; Laraia A; Antonucci A
    Boll Soc Ital Biol Sper; 1981 Jan; 57(2):145-8. PubMed ID: 6940605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The karyotype in the blastic crisis of chronic myeloid leukemia].
    Alimena G; Gastaldi R; De Cuia MR; Lombardi A; Dallapiccola B
    Recenti Prog Med; 1981 Mar; 70(3):259-70. PubMed ID: 7017849
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequent association between trisomy 15 and t(8;21)(q22;q22) in acute myeloid leukemia.
    Suzuki A; Ohyashiki K; Kimura Y; Matsuda S; Sano F; Yamada O; Ohno R
    Cancer Genet Cytogenet; 2001 Apr; 126(2):169-70. PubMed ID: 11394390
    [No Abstract]   [Full Text] [Related]  

  • 9. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
    Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
    Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex translocation (6;21;8), a variant of t(8;21), with trisomy 4 in a patient with acute myelogenous leukemia (M2).
    Shinagawa A; Komatsu T; Ninomiya H
    Cancer Genet Cytogenet; 1999 Feb; 109(1):72-5. PubMed ID: 9973964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant complex translocation t(8;15;21) in acute myeloblastic leukemia (M2) associated with bilateral chloroma.
    Sundareshan TS; Augustus M; Yasha TC; Shailaja SN; Lalitha N
    Cancer Genet Cytogenet; 1992 Nov; 64(1):35-7. PubMed ID: 1458447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A t (11;21) (13;q22) in Ph-positive chronic myelogenous leukemia.
    Wang TY; Raza A; Sait SN; Stein A; Schumer J; Sandberg AA
    Cancer Genet Cytogenet; 1988 Apr; 31(2):187-91. PubMed ID: 3162392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Karyotype in chronic myeloid leukemia in a blastic crisis. II. Trisomy 17].
    Geraci L; Palka G; Felaco M; Miscia S; D'Antuono A; Caramelli E
    Boll Soc Ital Biol Sper; 1981 Jan; 57(2):149-51. PubMed ID: 6940606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation 8;21 associated with acute nonlymphocytic leukemia in a Down syndrome child.
    Balogh E; Oláh E; Hunyadi K
    Cancer Genet Cytogenet; 1994 Aug; 76(1):72-3. PubMed ID: 8076357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Karyotypic evolution in a granulocytic sarcoma developing in a myeloproliferative disorder with a novel (3;4) translocation.
    Myint H; Chacko J; Mould S; Ross F; Oscier DG
    Br J Haematol; 1995 Jun; 90(2):462-4. PubMed ID: 7794773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two marker chromosomes in a patient with acute nonlymphocytic leukemia by two-color fluorescence in situ hybridization.
    Taniwaki M; Speicher MR; Lengauer C; Jauch A; Popp S; Cremer T
    Cancer Genet Cytogenet; 1993 Oct; 70(2):99-102. PubMed ID: 8242604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chromosomal abnormalities of the blastic phase of chronic myeloid leukemia].
    Stoll C
    Pathol Biol (Paris); 1982 Nov; 30(9):755-8. PubMed ID: 6760078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of cells with unmasked and masked Ph1 in a case of chronic myeloid leukemia in blastic phase.
    Pedersen B
    Cancer Genet Cytogenet; 1984 Jun; 12(2):129-37. PubMed ID: 6586280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome abnormalities in leukemia and lymphoma.
    Rowley JD
    Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.